Radiation drives tertiary lymphoid structures to reshape TME for synergized antitumour immunity
Open Access
- 23 October 2024
- journal article
- review article
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 26, e30
Abstract
Radiotherapy (RT) plays a key role in the tumour microenvironment (TME), impacting the immune response via cellular and humoral immunity. RT can induce local immunity to modify the TME. It can stimulate dendritic cell maturation and T-cell infiltration. Moreover, B cells, macrophages and other immune cells may also be affected. Tertiary lymphoid structure (TLS) is a unique structure within the TME and a class of aggregates containing T cells, B cells and other immune cells. The maturation of TLS is determined by the presence of mature dendritic cells, the density of TLS is determined by the number of immune cells. TLS maturation and density both affect the antitumour immune response in the TME. This review summarized the recent research on the impact and the role of RT on TLS, including the changes of TLS components and formation conditions and the mechanism of how RT affects TLS and transforms the TME. RT may promote TLS maturation and density to modify the TME regarding enhanced antitumour immunity.Keywords
This publication has 179 references indexed in Scilit:
- Radiation‐Induced Immunogenic Cell Death for Cancer RadioimmunotherapySmall Methods, 2023
- The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinomaClinical and Translational Medicine, 2022
- Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinomaCancer Medicine, 2022
- Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinomaThe Journal of Pathology: Clinical Research, 2022
- Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic CancerJAMA Oncology, 2021
- Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy DrugsJAMA Network Open, 2019
- Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancerCancer Immunology, Immunotherapy, 2018
- Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN‐γ and induces NK cell‐dependent lymphoma control without other immunotherapiesInternational Journal of Cancer, 2017
- Ionizing radiation induces CD20 surface expression on human B cellsInternational Journal of Cancer, 2001
- Roles of langerhans' cells and T-lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancerCancer, 1992